Screening for apparent total nitrosamine content with a thermal energy analyzer offers a rapid way of identifying contaminated drug products.
Andrew James
Advertisement
Andrew James is marketing director, Ellutia Limited.
Articles by Andrew James
Advertisement
Latest Updated Articles
Detecting Apparent Total Nitrosamine Content in Pharmaceutical DrugsPublished: August 2nd 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
Why Context Matters in Validating Biomarker Assays for Bioanalysis
3
Targeted high resolution metabolite screening workflows
4
An approach to streamline and simplify the identification of crucial metabolites from targeted protein degraders
5
